The Royal Marsden Hospital experience of trabectedin in patients with advanced soft tissue sarcoma (STS): Toxicity and efficacy in a nonselected group.
S. N. Banerjee
No relevant relationships to disclose
S. Mitchell
No relevant relationships to disclose
O. Al-Muderis
No relevant relationships to disclose
K. Pennert
No relevant relationships to disclose
A. Dunlop
No relevant relationships to disclose
C. Propert-Lewis
No relevant relationships to disclose
I. R. Judson
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Research Funding - ArQule; AstraZeneca; GlaxoSmithKline; Merck; Novartis; Pfizer; PharmaMar
M. R. Scurr
No relevant relationships to disclose